DK48382A - PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTAL DOSAGE UNIT CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE - Google Patents

PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTAL DOSAGE UNIT CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE

Info

Publication number
DK48382A
DK48382A DK48382A DK48382A DK48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A DK 48382 A DK48382 A DK 48382A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
preparing
procedure
dosage unit
unit containing
Prior art date
Application number
DK48382A
Other languages
Danish (da)
Other versions
DK157976C (en
DK157976B (en
Inventor
B E Haeger
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22935482&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK48382(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK48382A publication Critical patent/DK48382A/en
Publication of DK157976B publication Critical patent/DK157976B/en
Application granted granted Critical
Publication of DK157976C publication Critical patent/DK157976C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK048382A 1981-03-26 1982-02-04 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL, PARENTERAL, FOR QUICK RECONSTITUTION SUITABLE DOSAGE UNIT OF LYOPHILIZED SODIUM SALT OF 6- (2- (4-ETHYL-2,3-DIOXO-1-PIPERAZINYLETHYMIDOYLAMIDOID) 7-oxo-4-thia-1-azabicyclo (3,2,0) heptan-2-carboxylic acid DK157976C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24758681A 1981-03-26 1981-03-26
US24758681 1981-03-26

Publications (3)

Publication Number Publication Date
DK48382A true DK48382A (en) 1982-09-27
DK157976B DK157976B (en) 1990-03-12
DK157976C DK157976C (en) 1990-08-27

Family

ID=22935482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK048382A DK157976C (en) 1981-03-26 1982-02-04 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL, PARENTERAL, FOR QUICK RECONSTITUTION SUITABLE DOSAGE UNIT OF LYOPHILIZED SODIUM SALT OF 6- (2- (4-ETHYL-2,3-DIOXO-1-PIPERAZINYLETHYMIDOYLAMIDOID) 7-oxo-4-thia-1-azabicyclo (3,2,0) heptan-2-carboxylic acid

Country Status (23)

Country Link
JP (1) JPS57159708A (en)
AT (1) AT395533B (en)
AU (1) AU549784B2 (en)
BE (1) BE892541A (en)
CA (1) CA1209477A (en)
CH (1) CH652306A5 (en)
DE (2) DE19375106I2 (en)
DK (1) DK157976C (en)
ES (1) ES8302455A1 (en)
FR (1) FR2502624B1 (en)
GB (1) GB2095551B (en)
GR (1) GR78386B (en)
HK (1) HK39189A (en)
HU (1) HU186489B (en)
IE (1) IE52936B1 (en)
IL (1) IL64924A (en)
IT (1) IT1147916B (en)
LU (1) LU84031A1 (en)
NL (1) NL192664C (en)
NZ (1) NZ199632A (en)
PL (1) PL130564B1 (en)
SE (1) SE453153B (en)
ZA (1) ZA82605B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
GEP20115205B (en) 2003-10-23 2011-04-26 Otsuka Pharma Co Ltd Controlled release sterile injectable aripiprazole formulation and method
ITMI20051630A1 (en) * 2005-09-02 2007-03-03 Acs Dobfar Spa INJECTABLE STERILE PHARMACEUTICAL FORMULATION CONTAINING AT LEAST TWO ACTIVE PRINCIPLES
US9457026B2 (en) 2007-07-31 2016-10-04 Otsuka Pharmaceutical Co., Ltd. Methods for producing aripiprazole suspension and freeze-dried formulation
CN114200057A (en) * 2021-12-14 2022-03-18 坛墨质检科技股份有限公司 Preparation method of antibiotic medicine solid mixed standard substance capable of replacing standard solution

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2608507A (en) * 1949-08-20 1952-08-26 Sharp & Dohme Inc Dialkyl sulfamyl benzoic acids
CH546783A (en) * 1971-03-11 1974-03-15 Hoffmann La Roche PROCESS FOR THE PRODUCTION OF PENICILLOIC ACID DERIVATIVES.
JPS5817728B2 (en) * 1973-11-20 1983-04-09 山之内製薬株式会社 Ampicillin Sodium
IL47168A (en) * 1974-05-09 1979-07-25 Toyama Chemical Co Ltd Mono or dioxo piperazino(thio)carbonylamino derivatives ofpenicillins and cephalosporins and process for producing the same
JPS52143221A (en) * 1976-05-22 1977-11-29 Yamanouchi Pharmaceut Co Ltd Novel preparations for rectal administration
DE2623835C2 (en) * 1976-05-28 1978-03-02 C.H. Boehringer Sohn, 6507 Ingelheim Process for the manufacture of sodium amphicillin
JPS542337A (en) * 1977-06-08 1979-01-09 Toyama Chem Co Ltd Bactericidal composition for medical use
FR2403078A1 (en) * 1977-09-19 1979-04-13 Lafon Labor NEW PROCESS FOR THE PREPARATION OF PHARMACEUTICAL, COSMETIC OR DIAGNOSIS FORMS
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
DE2925009A1 (en) * 1979-06-21 1981-01-08 Basf Ag PREPARATION FOR SUBSTANCES, METHOD FOR THE PRODUCTION AND USE THEREOF

Also Published As

Publication number Publication date
GR78386B (en) 1984-09-26
DE3208505C2 (en) 1991-11-28
AT395533B (en) 1993-01-25
SE8200591L (en) 1982-09-27
DE19375106I2 (en) 2006-02-16
NZ199632A (en) 1985-07-12
HU186489B (en) 1985-08-28
IT1147916B (en) 1986-11-26
NL8201251A (en) 1982-10-18
LU84031A1 (en) 1982-07-08
ES509234A0 (en) 1982-12-16
JPH0219804B2 (en) 1990-05-07
DK157976C (en) 1990-08-27
CH652306A5 (en) 1985-11-15
GB2095551B (en) 1984-10-03
IT8248034A0 (en) 1982-03-19
PL235509A1 (en) 1982-12-20
NL192664C (en) 1997-12-02
IL64924A (en) 1985-07-31
HK39189A (en) 1989-05-19
IL64924A0 (en) 1982-04-30
AU549784B2 (en) 1986-02-13
BE892541A (en) 1982-09-20
IE52936B1 (en) 1988-04-13
CA1209477A (en) 1986-08-12
NL192664B (en) 1997-08-01
AU7986582A (en) 1982-09-30
ATA92982A (en) 1992-06-15
ES8302455A1 (en) 1982-12-16
JPS57159708A (en) 1982-10-01
DK157976B (en) 1990-03-12
FR2502624B1 (en) 1985-10-25
IE820703L (en) 1982-09-26
GB2095551A (en) 1982-10-06
PL130564B1 (en) 1984-08-31
DE3208505A1 (en) 1982-10-21
ZA82605B (en) 1982-12-29
FR2502624A1 (en) 1982-10-01
SE453153B (en) 1988-01-18

Similar Documents

Publication Publication Date Title
DK158873C (en) PROCEDURE FOR STABILIZING A LYOPHILIZED PHARMACEUTICAL INTERFERON PREPARATION
NO177038C (en) Process for the preparation of a pharmaceutical dosing system
DK162877C (en) DEPOT PLASTER FOR ADMINISTRATION OF A MEDICINE
FI831740L (en) FRAMEWORK FOR THE FRAMEWORK OF ETCES SESKVITERPENLAKTONHALTIGT PHARMACEUTICAL EXTRACT
DK365883A (en) PROCEDURE FOR PREPARING A LONG-EFFECTIVE PHARMACEUTICAL TABLE
NO168745C (en) PROCEDURE FOR PREPARING PHARMACEUTICAL MIXTURES
DK645788A (en) USE OF ERGOLIN DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
DK203879A (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL DOSAGE COMPONENT
DK220983D0 (en) PROCEDURE FOR THE PREPARATION OF A CYCLIC PEPTIDE DERIVATIVE DESIGNATED A-21978C
DK22879A (en) PROCEDURE FOR MANUFACTURING A MEDICINE DELIVERY SYSTEM
NO822749L (en) PROCEDURE FOR THE PREPARATION OF A CARBOSTYRIC DERIVATIVE
NO824112L (en) PROCEDURE FOR THE PREPARATION OF A FLUORBY PROFENDER DERIVATIVE
DK689188A (en) USE OF PIPERIDINE DERIVATIVES FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
DK48382A (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL PARENTAL DOSAGE UNIT CONTAINING A LYOPHILIZED PENICILLIN DERIVATIVE
DK352578A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION
DK221283D0 (en) PROCEDURE FOR THE PREPARATION OF A CYCLIC PEPTIDE DERIVATIVE DESIGNATED A-21978C
DK206582A (en) PROCEDURE FOR THE PREPARATION OF A FURAND DERIVATIVE
DK345681A (en) PROCEDURE FOR POSITIONING A PHARMACEUTICAL PREPARATION
DK651588D0 (en) APPLICATION OF A COMPOUND FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF FIBROMYALGIA
DK249083D0 (en) METHOD OF PREPARING A PHARMACEUTICAL PREPARATION FOR THE ADMINISTRATION OF ANTI-ANDROGENT ACTIVE COMPOUNDS
DK157183D0 (en) PROCEDURE FOR THE PREPARATION OF AN INSULIN DERIVATIVE
DK155682A (en) PROCEDURE FOR THE PREPARATION OF A PSYCHOTROTOPIC MEDICINE
DK212678A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION CONTAINING A NITROIMIDAZOLE
DK164771C (en) PROCEDURE FOR THE PREPARATION OF A NATIONAL PHARMACEUTICAL PREPARATION CONTAINING ERGOT-CYCLIC PEPTIDAL KALOIDS
DK568278A (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION